Research progress of targeted agents in the treatment of mantle cell lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 632-635, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-480030
ABSTRACT
Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma.The MCL is classified into two subtypes, some patients have a chronic/indolent course and the others have a more aggressive course and short survival.In recent years, some novel therapeutic target agents for MCL have reports.These target agents achieve efficacy comparable to conventional chemotherapy in relapsed/refractory MCL.Therapeutic targents for MCL include the surface antigens of B-cell lymphoma, B-cell receptor signaling, DNA damage response pathway and the cellular microenviroment.This review focused on the recent research progress of target agents in the treatment of MCL.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS